Sequella Global Tuberculosis Foundation – Trademark Portfolio
Entity Type: 03
Sequella Global Tuberculosis Foundation holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include AERAS. The owner is based in Rockville, MD.
9610 Medical Center Drive, #220
Rockville, MD 20850
Showing of trademarks Trademarks
Trademark Classifications
Sequella Global Tuberculosis Foundation's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Sequella Global Tuberculosis Foundation have?
Sequella Global Tuberculosis Foundation has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does Sequella Global Tuberculosis Foundation file in?
Sequella Global Tuberculosis Foundation files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Sequella Global Tuberculosis Foundation's most well-known trademarks?
Sequella Global Tuberculosis Foundation's registered trademark portfolio includes well-known marks such as AERAS. These are among 1 currently registered trademark in the portfolio.
What is Sequella Global Tuberculosis Foundation's trademark registration success rate?
Sequella Global Tuberculosis Foundation has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.